Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Real Time & Level II Data
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Biosyent Inc
V.RX
Alternate Symbol(s):
BIOYF
Healthcare
BioSyent Inc. is a Canada-based pharmaceutical company. The Company is focused on in-licensing or acquiring pharmaceutical and other healthcare products. It owns a legacy business that manufactures and markets Protect-It, a bio-friendly non-toxic product used in agriculture, which is operated by its subsidiary Hedley Technologies Ltd. It is a non-chemical, food-safe grain insecticide, which is...
used as a preventative treatment against insect infestations in stored grains and is marketed in Canada and the United States. Its products include Combogesic, Cathejell, FeraMAX Pd Therapeutic 150, FeraMAX Pd Powder 15, Proktis-M, RepaGyn, and cTIBELLA. Combogesic is for the short-term management of mild to moderate acute pain and the reduction of fever in adults. Cathejell is designed for ease of use and with patient comfort and safety in mind. FeraMAX Pd Therapeutic 150 is an oral hematinic that helps the body form red blood cells and is indicated for the treatment of iron deficiency anemia.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:RX)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
Next
(48)
•••
Daudau11
X
Post by
Daudau11
on Sep 19, 2023 8:36am
New Planet Microcap Presentation
BioSyent (TSX-V: RX): Specialty Pharmaceutical Company Focused on Commercializing Assets in Canada - YouTube
(1528)
•••
lscfa
X
Post by
lscfa
on Jul 07, 2023 9:07am
BioSyent Pharma to Introduce Gelclair®
https://www.globenewswire.com/news-release/2023/07/06/2700870/0/en/BioSyent-Pharma-to-Introduce-Gelclair-at-AHNS-11th-International-Conference-on-Head-and-Neck-Cancer.html
Unlocking the Future: Metals Co. Unveils Positive Pre-Feasibility Study for the Turnagain Nickel-Cobalt Deposit
posted Sep 22, 2023 9:00am by
Giga Metals Corp.
-
|
“We are very pleased to see the positive Pre-Feasibility Study,” said Kota Ikenishi, General Manager of the Battery Minerals Office, Mitsubishi Corporation. “We see a nickel project like Turnagain with low carbon intensity in a stable jurisdiction has a key role to play in the future of the nickel industry, in particular for the battery industry. We look forward to Turnagain’s potential to be further verified in works ahead.” ...read more
(640)
•••
Betteryear2
X
Post by
Betteryear2
on Jun 20, 2023 8:00pm
BioSyent Long-term Extension of Cathejell® Agreement
MISSISSAUGA, Ontario, June 20, 2023 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its wholly-owned subsidiary, BioSyent Pharma Inc
...more
(1528)
•••
lscfa
X
Post by
lscfa
on Apr 18, 2023 3:34pm
Presenting at Bloom Burton Conf.
April 25 https://www.bloomburton.com/conference/
(1528)
•••
lscfa
X
Post by
lscfa
on Mar 07, 2023 6:37pm
Launch of New FeraMAX® Pd Maintenance 45
https://stockhouse.com/news/press-releases/2023/03/07/biosyent-announces-launch-of-new-xa0-feramax-xae-pd-maintenance-45
(1528)
•••
lscfa
X
Comment by
lscfa
on Feb 08, 2023 7:03pm
RE:Jason Del Vicario- BNN - HOLD
Advil now sells an Advil + Acetaminophen product. It is 125mg/250mg Vs Combogesic 97.5mg/375mg. Is the different mix as effective? Is it to avoid infringing Combogesic? costs less too. https
...more
(1191)
•••
Possibleidiot01
X
Post by
Possibleidiot01
on Feb 08, 2023 2:42pm
Jason Del Vicario- BNN - HOLD
HOLD BioSyent Inc(RX-X) 08/02/2023 3% conviction level for him. Founder run and owned. 70-80% of its business is from an iron supplement, that
...more
(1528)
•••
lscfa
X
Post by
lscfa
on Dec 15, 2022 7:14pm
Dividend receipt in account
$0.04 per qtr
Thematica Insights Report and Investor Guide
Thematica: Battery Metals Report
Download our Investor’s Guide and learn how/why Battery Metals are playing a vital role in the EV Revolution.
Jeff Nielson
22 September 2023 09:28
(1528)
•••
lscfa
X
Post by
lscfa
on Dec 14, 2022 10:37pm
Exclusive Agreement for Oncology Supportive Care Product
MISSISSAUGA, Ontario, Dec. 14, 2022 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its subsidiary, BioSyent Pharma Inc., has signed an
...more
(1191)
•••
Possibleidiot01
X
Post by
Possibleidiot01
on Dec 14, 2022 6:49am
NCIB
Note the time period for the purchases - long term commitment to strategy. BioSyent has repurchased and cancelled a total of 2,200,625 Shares under NCIBs between December 10, 2018 and December 12
...more
(4)
•••
juanona
X
Post by
juanona
on Nov 16, 2022 10:30pm
Building for the future
In the presentation Ren stated they are making investments in people, processes and structure to support a $40-50M + business and get ready for the next accentuated growth phase. Their capital-light
...more
(0)
•••
PressRelease
X
Post by
PressRelease
on Nov 16, 2022 7:07pm
New Press Release - BioSyent Releases Q3 and YTD 2022 Financial Results
MISSISSAUGA, Ontario, Nov. 16, 2022 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for the three and nine months ended September 30, 2022. Key highlights include: Third quarter (Q3) 2022 Total Company Net Revenues of $6,790,971 increased...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Nov 10, 2022 9:00am
New Press Release - BioSyent Schedules Q3 and YTD 2022 Earnings Release for November 16, 2022
MISSISSAUGA, Ontario, Nov. 10, 2022 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three and nine months ended September 30, 2022 on Wednesday, November 16, 2022 after market hours. A presentation on the Company’s...
read article.
(951)
•••
prophetoffactz
X
Post by
prophetoffactz
on Nov 05, 2022 7:49pm
Interview:
KeyStone’s Stock Talk – Canadian & US Small-Cap Growth & Dividend Stocks, Tips & Portfolio Building Strategies (podbean.com)
(6439)
•••
retiredcf
X
Post by
retiredcf
on Nov 04, 2022 7:28am
Top Gainers
Essentially meaningless given the trading volume but better than moving in the other direction. GLTA Symbol/ Company Price $ Change $ Volume
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{currentVideo.storiesTitle}}:
{{story.companySymbol}}
{{story.companySymbol}}
{{story.headline}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Company Announces Name Change as They Turn Full Focus to Gold
SolarBank Completes Sale of 21MW Community Solar Sites to Honeywell International for $41mn
Charging Ahead: Your Key to Battery Metals & EV Insights - Free Report Here
A Digital Advertising Company Announces Updated Commercial Agreements with Large National Retailers
Nickel Miner Announces a Battery Supply Chain MOU with “PPES”, a JV Between Toyota and Panasonic